Literature DB >> 11992274

Close link between CD4+ and CD8+ T cell proliferation defects in patients with human immunodeficiency virus disease and relationship to extended periods of CD4+ lymphopenia.

Scott F Sieg1, Jonathan B Mitchem, Douglas A Bazdar, Michael M Lederman.   

Abstract

T cell proliferation failure is commonly associated with human immunodeficiency virus (HIV) infection. By examining T cell function on a single-cell basis, we found that CD4(+) T cell proliferation failure was often accompanied by CD8(+) T cell proliferation defects in patients with HIV disease. The defects are characterized by a proportional failure and reduced efficiency of precursor T cell proliferation after stimulation. In this study, patients who historically had low levels of circulating CD4(+) T cells were most likely to demonstrate cellular proliferation failure, regardless of current CD4(+) T cell counts. In contrast, neither historical nor current plasma HIV RNA levels were predictive of proliferation failure. These results suggest that mechanisms of T cell proliferation failure are more complex than can be explained by the direct effects of HIV replication and that therapeutic intervention to avoid prolonged periods of CD4(+) lymphopenia may be desirable for the preservation of immune function in patients with HIV disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992274     DOI: 10.1086/340509

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.

Authors:  Patricia Price; Niamh M Keane; Silvia Lee; Andrew F Y Lim; Elizabeth J McKinnon; Martyn A French
Journal:  Immunology       Date:  2006-06-22       Impact factor: 7.397

2.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

Authors:  Wei Jiang; Michael M Lederman; Peter Hunt; Scott F Sieg; Kathryn Haley; Benigno Rodriguez; Alan Landay; Jeffrey Martin; Elizabeth Sinclair; Ava I Asher; Steven G Deeks; Daniel C Douek; Jason M Brenchley
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

3.  In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.

Authors:  Benigno Rodriguez; Hernan Valdez; Christoph G Lange; Robert Asaad; Kathy Medvik; Scott F Sieg
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

4.  Frequencies of FoxP3+ naive T cells are related to both viral load and naive T cell proliferation responses in HIV disease.

Authors:  Benigno Rodriguez; Douglas A Bazdar; Nicholas Funderburg; Robert Asaad; Angel A Luciano; Gopal Yadavalli; Robert C Kalayjian; Michael M Lederman; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

5.  Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.

Authors:  David Gautier; Stéphanie Beq; Catarina S Cortesão; Ana E Sousa; Rémi Cheynier
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

6.  Interleukin-7 enhances proliferation responses to T-cell receptor stimulation in naïve CD4+ T cells from human immunodeficiency virus-infected persons.

Authors:  Douglas A Bazdar; Scott F Sieg
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

7.  Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.

Authors:  S Lee; C-A Almeida; M A H French; P Price
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

8.  Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.

Authors:  Timothy W Schacker; Phuong L Nguyen; Gregory J Beilman; Steven Wolinsky; Matthew Larson; Cavan Reilly; Ashley T Haase
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 9.  Antiretroviral therapy: when and what to start-- an American perspective.

Authors:  Timothy J Wilkin; Roy M Gulick
Journal:  Curr HIV/AIDS Rep       Date:  2004-06       Impact factor: 5.495

10.  Antiretroviral Therapy: When and What to Start-- An American Perspective.

Authors:  Timothy J. Wilkin; Roy M. Gulick
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.